ORKA FY 2021 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$91,000

Operating Income

-$19M

Net Income

-$19M

EPS (Diluted)

$-16.68

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$55M

Total Liabilities

$4M

Stockholders' Equity

$51M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$91,000	-$93,000	+2.2%
Operating Income	-$19M	-$10M	-98.0%
Net Income	-$19M	-$10M	-98.4%